Bone tumor

Disease Description (Causes and Symptoms)

• Definition summary: Neoplasm of the bone refers to benign or malignant tumors arising in bone. It is divided into primary bone tumors (e.g., osteosarcoma, chondrosarcoma, Ewing tumor) and metastatic cancer that has spread to bone from other organs (e.g., bone metastases from breast, lung, or prostate cancer).
• Causes and pathophysiology: The cause is unknown in most cases, but risk factors include genetic predisposition (such as RB gene abnormalities), previous radiation exposure, and certain underlying diseases (such as Paget disease). Primary malignant tumors arise from malignant transformation of osteoblasts or cartilage-lineage cells, while metastatic lesions occur when tumor cells attach to bone through the bloodstream and proliferate.
• Main symptoms: Local pain (worsening with activity, with frequent nighttime pain), a mass or swelling, a palpable lump, pathological fracture, and systemic symptoms such as fever or weight loss (in some cases). Some patients may have no symptoms at all.

Treatment Methods

• Diagnostic principles: Imaging studies (X-ray → CT/MRI to assess the extent), evaluation for systemic metastases (bone scan or FDG-PET), and biopsy for confirmation (core needle biopsy/incisional biopsy) are essential. The treatment plan is determined through a multidisciplinary approach based on histologic type, grade, stage, and the presence or absence of metastases.
• Primary benign tumors: If there are no symptoms and the risk of complications is low, observation may be appropriate. If there is pain, compression, deformity, or diagnostic uncertainty, ablation/curettage or excision may be performed.
• Primary malignant tumors:
  • Surgical treatment: Limb-sparing surgery (tumor resection followed by reconstruction) is performed whenever possible. Amputation (removal of the cancer) is performed when there is extensive involvement, recurrence, or when it is unavoidable.
  • Chemotherapy: For osteosarcoma, perioperative multi-agent chemotherapy (e.g., high-dose methotrexate, doxorubicin, cisplatin, ifosfamide, etc.) is often part of the standard clinical pathway. For Ewing sarcoma, combinations of vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide (representative protocols) are used. Chondrosarcoma responds poorly to chemotherapy, so surgical resection is prioritized.
  • Radiation therapy: Used for tumors that are sensitive to radiation, such as Ewing tumor, or for local pain control, hemostasis, and symptom relief.
• Metastatic disease (bone metastases) and supportive care:
  • Pain control (analgesics, local radiation therapy) and bone-strengthening agents (bisphosphonates: zoledronic acid; denosumab: a RANKL inhibitor) are used to prevent skeletal complications (fractures and hypercalcemia).
  • Orthopedic fixation (when there is a risk of fracture, an existing fracture, or instability) and local resection/reconstruction may be considered.
• Adverse effects and precautions: Monitoring for medication-specific adverse effects is necessary, including those of anticancer drugs (bone marrow suppression, vomiting, nephrotoxicity, cardiotoxicity, etc.), radiation (skin and soft-tissue damage), and bone-targeted therapy (hypocalcemia, risk of osteonecrosis of the jaw, and possible nephrotoxicity). Infection, delayed wound healing, and the need for rehabilitation may occur after surgery.
• Prognosis: Varies greatly depending on histologic type, grade, stage, and the presence or absence of metastases (localized primary tumors have a high likelihood of cure with treatment, while metastatic or high-grade malignant tumors have a poor prognosis).

Checklist Before an Outpatient Visit (Including Preparation Items and Sample Questions)

• Items to prepare:
  • A list of current medications (including prescription drugs, over-the-counter drugs, and supplements)
  • Past medical history (surgeries, history of cancer, radiation exposure, and whether there are hereditary diseases)
  • Copies of previous test results (X-ray/CT/MRI, blood tests, pathology reports, etc.)
  • A record of symptom changes: location and severity of pain (especially whether there is nighttime pain), changes in the size of the mass, functional limitations, fever, weight changes, etc.
  • Recent dental treatment history (especially important if bone-targeted therapy is scheduled to begin)
• Items that are useful to organize in advance for the outpatient visit:
  • The most bothersome symptoms and when they began
  • Medications being taken for pain control and their effects
  • Whether previous imaging and biopsy results are available, and their dates

Examples of General Questions to Ask the Doctor

• "What is the histologic diagnosis of my lesion (type and grade)?"
• "What additional tests do I need to undergo (imaging, systemic evaluation, genetic testing)?"
• "What are the recommended treatment options (surgery, chemotherapy, radiation, etc.), and what are the expected benefits and risks of each?"
• "What are the major side effects caused by treatment, and how can they be prevented and managed?"
• "When can I expect to undergo rehabilitation (physical therapy) and return to daily activities?"

Examples of Disease-Specific Questions

• For patients with primary malignancies (e.g., osteosarcoma):
  • "What chemotherapy is recommended before (or after) surgery (drug names and duration), and what are the expected response rate and major side effects?"
• For patients with bone metastases or those considering bone-targeted therapy:
  • "Before starting bone-targeted therapy (zoledronic acid or denosumab), are there any preparations needed, such as a dental examination or monitoring of blood calcium levels?"

Additional information: Diagnosis and treatment vary depending on the individual patient's biopsy results, imaging findings, and overall health status. Using the checklist and questions above during a consultation with a doctor can help the patient receive more specific and personalized recommendations.